The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Re. Regulatory News (FAR)

Share Price Information for Ferro-alloy Re. (FAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.25
Bid: 6.00
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.50 (8.333%)
Open: 6.25
High: 6.25
Low: 6.25
Prev. Close: 6.25
FAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First sale of ferro-molybdenum

10 Nov 2021 07:00

RNS Number : 8586R
Ferro-Alloy Resources Limited
10 November 2021
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018

 

10 November 2021

Ferro-Alloy Resources Limited ('FAR' or the 'Company' or the 'Group')

 

First sale of ferro-molybdenum and completion of testing of ferro-vanadium

 

Ferro-Alloy Resources Limited (LSE:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan, is pleased to announce it has made its first commercial sale of ferro-molybdenum and has completed testing of the production of ferro-vanadium.

 

As announced on 22 September 2021, the Company had started conversion of its calcium molybdate product into the higher value ferro-molybdenum. FAR are now pleased to announce that the first commercial contract for sale has been signed.

 

The Company is now recovering around 4.5 tonnes per month of ferro-molybdenum as a by-product from its recovery of vanadium from bought-in concentrates and this is expected to grow as throughput of the plant increases. The molybdenum is initially recovered as calcium molybdate which was previously sold at a discount to prevailing molybdenum prices, but this is now being converted and sold as ferro-molybdenum, avoiding the discount.

 

In addition, the Company is pleased to announce that testing of the production of ferro-vanadium using a similar process to ferro-molybdenum has been successfully completed, allowing the Company to choose in future whether to sell its vanadium production as vanadium pentoxide or ferro-vanadium, depending on which is the most profitable taking account of pricing and costs. Ferro-vanadium typically sells for some US$3-$4 per kilogramme more than for the same quantity of vanadium in vanadium pentoxide, roughly reflecting conversion costs, but the ability to make ferro-vanadium opens up a wider range of customers and, in particular, customers in Kazakhstan which minimise transport costs and provide other fiscal advantages.

 

The Company's full range of products available for sale now consist of:

 

· Ammonium metavanadate (AMV)

· Vanadium pentoxide

· Ferro-vanadium

· Ferro-molybdenum

· Nickel concentrates

 

 

Nick Bridgen, CEO, commented: "These are two important steps towards maximising the value we get from our exiting operation, and further demonstrates our growing technical expertise. 

 

"With vanadium prices at a relatively high and stable level, and with our growing production, our existing operations now fulfil their objective of providing cash flows to support our feasibility study and ongoing development of the Balasausqandiq deposit."

 

 

For further information, visit www.ferro-alloy.com or contact:

 

Ferro-Alloy Resources Limited

Nick Bridgen (CEO)

info@ferro-alloy.com

 

Shore Capital

(Corporate Broker)

VSA Capital

Jerry Keen/Toby Gibbs

 

Andrew Monk/Simon Barton

+44 207 408 4090

 

+44 (0)203 005 5000

St Brides Partners Limited

(Financial PR & IR Adviser)

Catherine Leftley

+44 207 236 1177

 

About Ferro Alloy Resources Limited:

The Company's operations are all located at the Balasausqandiq deposit in Kyzylordinskaya Oblast in the South of Kazakhstan. Currently the Company has two main business activities:

a) the high grade Balasausqandiq vanadium project (the "Project"); and

b) an existing vanadium concentrate processing operation (the "Existing Operation") 

Balasausqandiq is a very large deposit, with vanadium as the principal product together with several by-products. Owing to the nature of the ore, the capital and operating costs of development are very much lower than for other vanadium projects. 

A reserve on the JORC 2012 basis has been estimated only for the first ore-body (of five) which amounts to 23 million tonnes, not including the small amounts of near-surface oxidised material which is in the Inferred resource category. In the system of reserve estimation used in Kazakhstan the reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2 to 5. 

There is an existing concentrate processing operation at the site of the Balasausqandiq deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant which was then adapted to treat concentrates and expanded. Further expansion is being undertaken which is expected to result in annualised production capacity of around 1,500 tonnes of contained vanadium pentoxide plus significant by-product molybdenum. 

The strategy of the Company is to develop both the Project and the Existing Operation in parallel. Although they are located on the same site and use some of the same infrastructure, they are separate operations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFZMGMNLMGMZM
Date   Source Headline
19th Mar 20214:35 pmRNSPrice Monitoring Extension
19th Mar 20212:05 pmRNSSecond Price Monitoring Extn
19th Mar 20212:00 pmRNSPrice Monitoring Extension
18th Mar 202112:00 pmRNSIssue of Equity
17th Mar 20219:05 amRNSSecond Price Monitoring Extn
17th Mar 20219:00 amRNSPrice Monitoring Extension
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 202112:45 pmRNSDirector Share Purchase
16th Mar 202111:05 amRNSSecond Price Monitoring Extn
16th Mar 202111:00 amRNSPrice Monitoring Extension
16th Mar 20219:06 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
15th Mar 202111:05 amRNSSecond Price Monitoring Extn
15th Mar 202111:00 amRNSPrice Monitoring Extension
15th Mar 20219:05 amRNSSecond Price Monitoring Extn
15th Mar 20219:00 amRNSPrice Monitoring Extension
15th Mar 20217:01 amRNSStrategic Investment & Appointment of Chairman
15th Mar 20217:00 amRNS2020 Production & Operations Update Issue of Bonds
11th Jan 20217:00 amRNSIssue of Bonds
11th Nov 20207:00 amRNSIssue of Bonds
2nd Nov 20207:00 amRNSResult of AGM
26th Oct 20207:00 amRNSCommercial Production & Sales of Calcium Molybdate
22nd Oct 202011:15 amRNSHolding(s) in Company
20th Oct 20209:05 amRNSSecond Price Monitoring Extn
20th Oct 20209:00 amRNSPrice Monitoring Extension
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202011:06 amRNSSecond Price Monitoring Extn
19th Oct 202011:00 amRNSPrice Monitoring Extension
7th Oct 20207:00 amRNSProduction and Progress Update
2nd Oct 20207:00 amRNSNotice of AGM
30th Sep 20207:00 amRNSInterim Results
16th Sep 20207:00 amRNSFinancing and Operational Enhancement
3rd Sep 20207:00 amRNSShare Subscription
2nd Sep 20204:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20204:35 pmRNSPrice Monitoring Extension
2nd Sep 20207:00 amRNSElectrolyte for Vanadium Flow Batteries & AIX Bond
30th Jun 20207:00 amRNSIssue of Equity to Directors
29th Jun 20207:00 amRNSFinal Results
12th Jun 20207:00 amRNSOperational and Financing Update
2nd Jun 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20202:05 pmRNSSecond Price Monitoring Extn
2nd Jun 20202:00 pmRNSPrice Monitoring Extension
14th May 202011:34 amRNSIssue of Equity
1st May 20207:00 amRNSFull Year Results Deferral and Ops Update
3rd Apr 20207:00 amRNSIssue of Ordinary Shares & Total Voting Rights
19th Mar 20207:00 amRNSDirector Lock-In & Orderly Marketing Arrangement
21st Feb 20204:18 pmRNSConfirmation of cancellation of listing from KASE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.